News

Sinovac Biotech, a China-based biopharmaceutical company, has reported a net income of $2.4m, or $0.06 per diluted share, for the fourth quarter of 2008, compared to $2m, or

According to Sun Pharma, these oxycodone tablets are therapeutically equivalent to Roxicodone tablets from Xanodyne Pharmaceuticals and are available in three strengths: 5mg, 15mg and 30mg. Oxycodone is

The companies have agreed to offer their services together to parties such as pharmaceutical companies, who may be seeking a patient-friendly intranasal Phylomer peptide developed against their target

The funding was triggered by the company’s achievement of a major milestone towards the development of its image guided cancer therapy device, the Renaissance system. The financing was

Through the collaboration, iZumi and Kyoto University’s Center for iPS Cell Research and Application (CiRA) will exchange part of their representative human induced pluripotent stem (iPS) cell lines

Thallion Pharmaceuticals, a biotechnology company developing pharmaceutical products in the areas of oncology and infectious disease, has reported a net loss of $3.24m or $0.10 per share in

ChemGenex Pharmaceuticals, an Australian biopharmaceutical development company, has completed a private placement to sophisticated and institutional investors in Australia and internationally to raise A$10m. ChemGenex placed 23.25 million

Celldex Therapeutics, a biopharmaceutical company, has expanded its precision targeted immunotherapy platform by acquiring exclusive rights to FMS-like tyrosine kinase 3 ligand and CD40 ligand, from Amgen. Specific

Array BioPharma, a biopharmaceutical company, has dosed its first type 2 diabetic patient in a Phase I clinical trial with its novel small molecule glucokinase activator, ARRY-403. In